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2. Structured abstract. 
Purpose 
To present two iPad applications (apps) for measuring Visual Acuity (VA) and Contrast 
Sensitivity Function (CSF) and to assess reliability and agreement with a commercial 
screening device.  
Methods 
Forty-five healthy subjects with monocular corrected visual acuities better than 0.2 
logMAR participated in the agreement study of VA and CSF with iPad and Optec 6500. 
The measurement of VA was performed in accordance with the Amblyopia Treatment 
Study protocol with the AmblyopiaVA and the Early Treatment of Diabetic Retinopathy 
Study (ETDRS) with the Optec 6500. The CSF was measured with the ClinicCSF  for iPad 
and the Functional Acuity Contrast Test (FACT) included in the Optec 6500. Twenty-five 
subjects from the total completed three sessions of measurements, one per week, and their 
results were considered in the test-retest study. We performed Bland-Altman analyses to 
assess the agreement and Deming regressions to calculate Mean Differences (MDs) and 
Limits of Agreement (LoAs). Coefficients of reproducibility (r) with exchangeable 
replicates were also computed. 
Results 
MD of VA was 0.06 logMAR better with AmblyopiaVA than with ETDRS (p<0.001) and 
LoAs were around ±0.2 logMAR. Test-retest reliability was better with AmblyopiaVA 
(r=0.15) with no statistically significant differences between days (p>0.05). A good 
agreement with no significant differences (p>0.05) was obtained with ClinicCSF and 
FACT. MDs were below 0.05 log units at all the spatial frequencies but non-constant LoAs 
were manifested at 3.6 and 18 cpd. Null hypotheses of same medians along days were 
accepted for both tests (p>0.05) but reliabilities were poorer with the increment of the 
spatial frequency.  
Conclusions 
The iPad tests showed a good agreement with conventional tests and may be a convenient 
and faster alternative to some existing commercial screening devices. On the other hand 
future improvements in test-retest reliabilities should be done for the screening of CSF. 








Vision screening programs are intended to identify eye problems which occur in children1 
or adults2 and refer them for further evaluation. Although there is a battery of screening 
methods designed to detect specific eye disorders, some screening techniques can be 
considered “multi-purpose,” minimizing the need for several individual tests.3  For instance, 
visual acuity (VA) is considered an essential part of any eye examination4 and is used in the 
screening of refractive errors5 and amblyopia.6 On the other hand, Contrast Sensitivity 
Function (CSF) is considered an additional test for specialized clinical evaluation,7 and has 
been generally accepted as a better predictor of visual performance than high contrast 
VA.8,9,10  
Several tests and methods have been proposed for the assessment of VA and CSF. 
Nowadays, the Early Treatment of Diabetic Retinopathy Study (ETDRS) testing protocol is 
generally accepted as the gold standard of VA measurement in adults.11,12,13 With regard to 
contrast sensitivity (CS), although the Pelli-Robson14 chart is considered the gold standard 
to compare CS tests based on optotypes,15 currently there is not a commercial gold standard 
test to measure CSF by sinusoidal gratings. An alternative could be to measure CSF using a 
computer-driven cathode ray tube (CRT), but CSF depends on several test parameters such 
as the psychophysical method, therefore differences may be found depending on the 
selected parameters.16   
Despite the fact that commercial clinical tests are not able to measure absolute CSF like the 
CRTs methods do, they could be a good option to compare new screening tests since they 
are generally accepted by the research community.17,18,19,20 Clinical CS tests commonly use 
9 patches of sinusoidal gratings with different contrast levels. They could differ in the step 
sizes, ranges, or the psychophysical method to achieve the threshold.19 The most used are 
the Functional Acuity Contrast Test (FACT)21  and the Vector Vision CSV-1000.22 Some 
devices which include VA and CS tests are available to screen vision such as the Optec 





Ever since tablets appeared, new applications (apps) have been proposed in the field of 
visual science.25,26,27 The big advantage of using these portable devices is the potential 
standardization of results since there are many common models which share characteristics 
such as screen chromaticity. Therefore, it can be hypothesized that if a developer takes into 
account the technical data of the tablets in the design of an app, any operator who uses the 
same device in any part of the world will approximately measure the visual function in the 
same conditions. However, it still has to be demonstrated that there are no changes in the 
screen properties among screens in the same tablet device.28 
The assessment of the CS with a commercial tablet device (iPad) has recently been 
proposed under two different approaches: Dorr et al.29 implemented the quick CSF method 
of Lesmes et al.30 to evaluate 16 spatial frequencies log-spaced from 0.42 to 13.7 cycles per 
degree (cpd). This test was validated with measurements obtained from four normally 
sighted subjects on specialized laboratory equipment but it is rather time-consuming for 
screening purposes. On the other hand, Kollbaum et al.27 developed a more elementary test 
consisting of two letters on each page of an iBook, having 0.1 log units of difference 
between pages. This test was compared to the Pelli-Robson and Freiburg Acuity and 
Contrast Tests and gave significantly lower values with the first one and good agreement 
with the second one. As a disadvantage, Kollbaum’s test measures CS instead of CSF 
because it uses optotypes rather than sinusoidal gratings.  
The aim of this study is to introduce two new iPad apps which represent an alternative to 
other expensive and large-format screening instruments, such as the Optec6500.31 
AmblyopiaVA and ClinicCSF are the names of these apps designed for a fast screening of 
VA and CSF, respectively. The VA and CS records and test-retest reliabilities are 




The proposed apps were developed with ActionScript 3.0 programming language for 
mobile devices and then compiled for IOS with Adobe Flash Builder (Adobe Systems, 




display (2048-by-1536-pixel resolution at 264 pixels per inch (ppi)). A Spyder4Elite 
colorimeter was used to measure the chromaticity of the iPad screen for maximum 
brightness and the room lighting was obtained with a LX1330B Luxmeter.  
Visual Acuity (AmblyopiaVA) 
In the AmblyopiaVA app, each subject had to recognize which of the four letters (HOTV) 
appeared isolated in the centre of the screen (Figure 1, left). On each visual acuity level, a 
black crowded optotype was presented over a white background with luminance of 342 
cd/m2. This value corresponded to the maximum brightness of the screen and was chosen to 
ensure that luminance was the same at all the trials. An automated psychophysical method 
described by the Amblyopia Treatment Study (ATS) testing protocol  was used to reach the 
VA threshold,33 thereby the operator needed only to push the corresponding button 
according to the answer given by the observer. An empty button was placed next to the 
HOTV buttons to be pressed when the observer could not recognize the letter.  Even though 
the ATS protocol consists of a binocular pre-test and a monocular screening, the first one 
was omitted and subjects directly started with monocular screening at 0.8 logMAR. The 
reinforcement phase described in the ATS protocol was also omitted and the application 
automatically passed from phase 1 to phase 2. The presentation distance for the 
AmblyopiaVA app was 3 m and the time it took to complete each measurement was around 
one minute per eye. 
Figure 1 
Contrast Sensitivity (ClinicCSF) 
In the ClinicCSF app, sinusoidal gratings were used as stimuli for spatial frequencies of 3, 
6, 12 and 18 cpd. The contrast of gratings was determined by the luminance difference of 
the light and dark bars, as described by the Michelson contrast ratio.34  The sinusoidal 
gratings appear in a vertical orientation or are tilted ±15º from the vertical and are masked 
by circular patches with blurred edges that fade the gratings into a grey background of 
mean luminance (85cd/m2). The patch size was configured to subtend 1º of visual angle at a 




each spatial frequency and each orientation. Stimuli were programmed with MATLAB 
software (The MathWorks, Natick, MA) and the library COLORLAB.35 A more detailed 
description of the ClinicCSF design used in this study has recently been published as 
ClinicCSFv2.36 The CS values for each level were the same as the FACT in order to obtain 
comparable results between instruments (Table 1). The psychophysical procedure was also 
programmed to follow the one used in the FACT. It consists of three steps: (1) starting at 
the first level, it goes up one level after each right answer until the observer fails; (2) the 
same procedure as the previous step but starting two levels below the level in which the 
answer was wrong in step 1; (3) the exam ends after two successive wrong responses, the 
CS threshold corresponding to the latest correct answer. The time it took to complete each 
measurement was around two minutes and a half per eye. 
Table 1 
Subjects and Procedures 
Forty-five subjects,  comprised of 21 males (mean age: 36 ± 11 years) and 24 females 
(mean age: 33 ± 10 years), were recruited from university staff and students at the 
University of Valencia. Exclusion criteria included strabismus or any cause of monocular 
reduced visual acuity worse than 0.2 logMAR with habitual correction (measured with 
ETDRS). Informed consent was obtained from each subject just before starting the 
procedures. The research was conducted in accordance with the principles laid down in the 
Declaration of Helsinki.  
All trials were performed in the same room illumination (15 Lux). The same procedure was 
carried out in all sessions by the same operator and with the patient wearing the habitual 
correction. VA and CSF were measured with the iPad test and, after a short break, with the 
Optec6500 using the day testing option (85cd/m2 target illumination). Twenty-five subjects 
from the total were cited for two more sessions, spaced a week apart, in order to evaluate 







Although both of the subjects’ eyes were measured during testing procedures, only one was 
included in the agreement and reliability analyses after a random selection.37 VA and CSF 
variables were not normally distributed therefore non-parametric tests were employed. 
Statistical significances of VA and CS inter-eyes and inter-test differences were assessed 
with the Wilcoxon signed-rank test. On the other hand, differences between tests followed 
an approximately normal distribution, therefore the Bland-Altman (BA) analysis was 
performed to evaluate the agreement between iPad apps and Optec6500 tests and to assess 
test-retest reliabilities.38 The MethComp (version 1.25) package was used with the R 
statistics software (version 3.1, R Development Core Team, 2014) in order to complete the 
statistical analyses described below. 
Agreement. Differences between measurements for each test were plotted against the 
average and the 95% limits of agreement (LoAs) were computed depending on whether the 
average difference and the variability of differences were constant throughout the range of 
measurement.39 We checked the hypotheses of constant differences and constant standard 
deviations by means of a Deming regression (function DA.reg).40 If the corresponding p 
values for both hypotheses were significant (p<0.05), conversion equations were employed 
on the plot and MDs or LoAs were represented considering linear correlations (function 
BA.plot, parameters dif.type = "lin", sd.type = "lin").  
Reproducibility. A Friedman 2-way analysis of variance by ranks with multiple 
comparisons was used to evaluate differences in medians among the three days.41 The 
residual standard deviation (  with each test was computed with the data from the 
subjects who completed a total of 3 sessions (replicates). LoAs were estimated again 
considering models of exchangeable or linked replicates. A random permutation (function 
perm.repl) was done comparing the resulted LoAs with the original data by a BA plot in 
order to apply the exchangeable or linked models proposed by Cartensen et al.42 Since the 
random permutation of replicates had little effect in the LoAs, they were computed as 




(r) of each test defined as (exchangeable replicates) in order to know if test 
agreement might be related with test reliability (RepCoef  in function BA.est).42  
Results 
Visual Acuity 
No statistically significant differences were found in the comparison between right and left 
eyes with both tests, although as it can be seen in Figure 2A, the difference between eyes 
was higher with ETDRS (p=0.09) than with AmblyopiaVA (p=0.85) at around 0.1 logMAR. 
In the comparison between tests (Figure 2B), VA scores obtained with AmblyopiaVA had 
better results than those obtained with ETDRS with a MD of 0.06 logMAR (p<0.001). This 
difference would be approximately three letters on a logMAR chart with five letters per 
line. The null hypotheses of constant MDs and constant SDs were accepted (p>0.05) which 
suggest that EDTRS results could easily be predicted with the AmblyopiaVA along the range 
of visual acuities measured (-0.2 to 0.2) by simply subtracting MD from AmblyopiaVA 
results. 
Figure 2 
Friedman test showed significant median differences between days χ2 (2, n=25) =12.15, 
p=0.002 with ETDRS. The median was 0 logMAR for the first day and -0.1 logMAR for 
the other two days. On the other hand, medians with AmblyopiaVA were -0.1 logMAR in 
the three days with no statistically significant differences among days χ2 (2, n=25) =2.61, 
p=0.27. The number and percentage of subjects that reported differences within 0.1 
logMAR in the three days were 24 (96%) with AmblyopiaVA and 21 (84%) with ETDRS. 
The permutation indicated that replicates should be treated as exchangeable, therefore a 
recalculation of LoAs was developed by this condition obtaining a value of ±0.2 logMAR, 
similar to that reported in the agreement study (Figure 2B). Coefficients of reliability (r) 
were 0.15 logMAR for AmblyopiaVA and 0.17 logMAR for ETDRS.  
Contrast Sensitivity 
The analyses of median differences between right and left eyes were not significant for all 




frequencies of 3 and 6 cpd which was manifested by a negative skewed distribution in the 
box plot diagrams (Figure 3). Even though the distributions of ClinicCSF and FACT were 
less similar with the increment of the spatial frequency, no statistically significant 
differences were found at any spatial frequency (p>0.05). 
Figure 3 
MDs were below 0.05 log units for all spatial frequencies and LoAs were increased with 
the spatial frequency (Figure 4). Deming regression showed that although there were 
constant MDs for all the spatial frequencies (p > 0.05), constant SDs could not be assumed 
for 3, 6 and 18 cpd (p < 0.05). Therefore LoAs for non-constant SDs were also represented 
on BA plots with the corresponding equations to compute the LoAs along the average of 
test measurements (a).  
Figure 4 
Table 2 shows that even though no statistical significant differences were found in the 
Friedman analysis of variance of the three days, a low reproducibility was obtained with 
both tests and this was slightly better with the FACT. Considering step sizes between 
patches around 0.15 log units, reproducibility coefficients (r) from Table 2 correspond to a 
maximum difference of 2, 3, 4 and 4 patches for 3, 6, 12 and 18 cpd, respectively, with 
ClinicCSF. Reproducibility slightly improved to 2 patches for 3, 6, and 12 cpd while a 
maximum difference of 3 patches was obtained for 18 cpd with FACT. The r was very 
close to the LoAs, therefore the lack of agreement between ClinicCSF and FACT is mainly 










We found statistically significant differences between the records of VA obtained with 
AmblyopiaVA and ETDRS, resulting in a better VA of 0.06 logMAR with our test. This 
result is coincident with the outcomes reported by Rice M. et al.43 who also found an MD 
of 0.06 logMAR between ATS and ETDRS. Leone J et al.44 also found a better VA with 
the ATS procedure than with HOTV and ETDRS charts even though the latter ones 
incorporated a staircase method that improves the VA results.13 Therefore, the apparent 
lack of agreement between tests in our study can be attributed to the differences in the VA 
protocols rather than to the use of different instruments (iPad Retina or Optec 6500). It is 
also important to note that even though non-statistically significant differences were found 
between eyes with both tests, lower differences were manifested with AmblyopiaVA, which 
might help in the amblyopia diagnosis with a lower rate of false positive referral rates.44 In 
regards to test reliabilities, we obtained a better coefficient of reproducibility with 
AmblyopiaVA than with ETDRS. 96% of subjects reported differences within 0.1 logMAR 
with the AmblyopiaVA, this percentage is consistent with the 93% previously reported with 
ATS protocol.33 This better reliability is mainly due to the ATS protocol. It is important to 
note that, even though we applied little modifications to reduce time testing (such as 
skipping the reinforcement phase), reliability has not been reduced. Therefore we believe 
that the reinforcement phase might not be necessary to improve testing reliability in the 
ATS procedure. 
Unlike a previous work carried out with another VA test for iPad,26 we did not have glare 
problems. Given that our study was conducted in a room without any kind of reflections 
over the screen, there is a possibility that dissimilar results would have arisen if the VA had 
been measured in a high light environment with reflections over the screen. One negative 
factor regarding our methodology might be that the brightness of the screen was set on the 
maximum level (342cd/m2), which is over the recommended background luminance.45 We 
decided to perform the study in this way to ensure that all evaluations were conducted 
under the same lighting conditions. Future work will concentrate on developing a system to 
measure environmental illumination and automatically set up the background luminance in 






Dorr M. et al.29 have recently demonstrated that CSF assessment on a mobile device may 
be indistinguishable from that obtained with specialized laboratory equipment. Although 
they implemented the quick CSF method30 that reduces the testing time to no more than 5 
minutes, this method could still be very time-consuming for screening procedures. Thus our 
proposal is a valuable alternative since it can be completed in half the time. The ClinicCSF 
results demonstrated a good agreement with FACT with no statistically significant 
differences between tests at any spatial frequency. Specifically, the MDs were lower than 
0.05 log units for all spatial frequencies. In a previous work, Franco et al.17 found MDs of 
0.3, 0.08, 0.2 and 0.18 log units for 3, 6, 12 and 18 cpd respectively in the comparison 
between VCTS-6500 and CSV-1000. The differences were statistically significant probably 
because in that study they used tests which differ in step sizes between CS levels.  
We found a lower agreement between tests at high spatial frequencies. It is important to 
note that this fact is related to test-retest reliabilities of ClinicCSF and FACT which were 
also poorer with the spatial frequency increment. Pesudovs et al.19 also found similar test-
retest reliabilities, being poorer with the increment of the spatial frequency even though this 
fact was not highlighted in their discussion. In addition, a non-constant standard deviation 
of test differences along the range of contrast sensitivities was manifested for spatial 
frequencies of 3, 6, and 18 cpd with wider LoAs with the decrease of CS. Although 
Kollbaum et. al27 used optotypes which contain a wide range of spatial frequencies whose 
relative weight depend on the letter of its size unlike sinusoidal gratings,46  they reported a 
reliability dependency with CS levels. Therefore, it is possible that the ClinicCSF and 
FACT reliabilities also vary in subjects who present any ocular disease that affects the CSF. 
ClinicCSF has several advantages in regards to the Kollbaum et. al test, including testing 
different spatial frequencies, random presentation of grating orientation to avoid the 
learning effect and the possibility of optimising the psychophysical method to improve 
reliability. Research into improving reliability with a better psychophysical method and 




patches are already in progress in our group. In fact, a staircase psychophysical procedure 
has recently demonstrated a considerable reduction of the LoAs.36  
Both ClinicCSF and FACT presented ceiling effects for some spatial frequencies because of 
characteristics of the sample (healthy subjects wearing habitual correction). This suggests 
that subjects in the sample probably had a better CS than was achieved with both tests. This 
fact of screening CSF tests has been widely studied 47,48  and even though people with poor 
CS have not participated in our study it can be expected that a floor effect would be also 
presented with this other sample type.  
Conclusion  
In this work we have presented two iPad apps for screening visual performance by 
measuring VA and CS. These solutions are proposed as an alternative against expensive 
and large-format instruments, such as Optec6500, that are more difficult to transport and 
store than portable devices. Specifically, we have obtained very good results for the 
measurement of VA. Differences in VA measured with AmblyopiaVA and ETDRS can be 
attributed to the ATS procedure and are similar to those reported previously by other 
authors. In our case, the use of a standardized procedure improved test-retest reliability and 
thus we suggest that this app could be a valid low-cost alternative to the current electronic 
visual acuity system.49 In addition, even though CS with AmblyopiaVA has not been 
assessed in this study, the app offers the possibility of measuring VA at different levels of 
contrast (0 to 100%). This is an interesting point for future clinical research considering 
current studies of perceptual learning in amblyopia cases.50 This variation of CS added to 
fact that measurement of VA may be performed at multiple distances (40cm to 3m), makes 
AmblyopiaVA a test that can be used for other applications as a measurement of visual 
performance with multi-focal intraocular lenses or multi-focal contact lenses. 
Regarding contrast sensitivity, we obtained similar results with ClinicCSF and FACT. In 
fact, the ClinicCSF has been developed with the same contrast sensitivity levels and testing 
procedure than the FACT to compare their results. Further developments are in progress to 
find the best contrast sensitivity levels for an iPad and to improve the reliability with 




correspond to normal subjects. Clinical studies are presently being conducted with 
AmblyopiaVA in amblyopic children and also with ClinicCSF in patients suffering from 
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Figure 1. iPad application patterns. Crowded optotype in the AmblyopiaVA (left) 
and sinusoidal grating in the ClinicCSF (right). 
Figure 2. (A) Box plot diagrams showing visual acuities from right and left eyes 
measured with both visual acuity tests. (B) Bland–Altman plot showing the mean 
difference against the average of AmblyopiaVA and ETDRS (solid line), limits of 
agreement are also represented by dashed lines.  
Figure 3. Box plot diagrams showing the contrast sensitivities obtained with 
ClinicCSF and FACT for spatial frequencies of 3, 6, 12 and 18 cpd. The boxes 
indicate the first and third quartiles, the dark horizontal lines represent the median, 
and the extreme horizontal lines are the minimum and maximum. Other points 
represent outliers. 
Figure 4. Bland–Altman plots showing the mean difference against the average of 
ClinicCSF and FACT. Mean differences were nearly zero for all spatial 
frequencies even though the limits of agreement (dashed lines) were increased 
with the spatial frequency and with the decrease in average of contrast sensitivity 
for 3, 6 and 18 cpd. The variable a in the LoAs equations corresponds to the 
contrast sensitivity average from both tests. 
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